Journal of Neurogastroenterology and Motility : eISSN 2093-0887 / pISSN 2093-0879

Cited by CrossRef (13)

  1. Ya Qi Song, Yong Li, Su Li Zhang, Jie Gao, Shun Yi Feng, Gianluigi Forloni. Proton pump inhibitor use does not increase dementia and Alzheimer’s disease risk: An updated meta-analysis of published studies involving 642305 patients. PLoS ONE 2019;14:e0219213
    https://doi.org/10.1371/journal.pone.0219213
  2. Yoshikazu Kinoshita, Norihisa Ishimura, Shunji Ishihara. Management of GERD: Are Potassium-Competitive Acid Blockers Superior to Proton Pump Inhibitors?. American Journal of Gastroenterology 2018;113:1417
    https://doi.org/10.1038/s41395-018-0183-8
  3. Raimunda SN Brilhante, Maria G da Rocha, Jonathas S de Oliveira, Jaime DA España, Vandbergue S Pereira, Débora de SCM Castelo-Branco, Waldemiro de A Pereira-Neto, José JC Sidrim, Rossana de A Cordeiro, Marcos FG Rocha. Proton pump inhibitors versus Cryptococcus species: effects on in vitro susceptibility and melanin production. Future Microbiology 2019;14:489
    https://doi.org/10.2217/fmb-2018-0340
  4. Johannes Roksund Hov. Editorial: proton pump inhibition - microbial complications beyond dysbiosis. Aliment Pharmacol Ther 2019;50:962
    https://doi.org/10.1111/apt.15495
  5. Ann R. Lurati. Effects of Menopause on Appetite and the Gastrointestinal System. Nursing for Women's Health 2018;22:499
    https://doi.org/10.1016/j.nwh.2018.09.004
  6. Kate N. Wang, J. Simon Bell, Edwin C. K. Tan, Julia F. M. Gilmartin-Thomas, Michael J. Dooley, Jenni Ilomäki. Proton Pump Inhibitors and Infection-Related Hospitalizations Among Residents of Long-Term Care Facilities: A Case–Control Study. Drugs Aging 2019
    https://doi.org/10.1007/s40266-019-00704-6
  7. A Dua, M Venu. Associated risks of proton pump inhibitors and their influence on prescribing habits: is change truly warranted?. 2019;32
    https://doi.org/10.1093/dote/doy103
  8. Yoshikazu Kinoshita, Sachiko Oouchi, Takashi Fujisawa. Eosinophilic gastrointestinal diseases – Pathogenesis, diagnosis, and treatment. Allergology International 2019;68:420
    https://doi.org/10.1016/j.alit.2019.03.003
  9. Yang Won Min, Danbee Kang, Ju-Young Shin, Minwoong Kang, Joo Kyung Park, Kwang Hyuck Lee, Jong Kyun Lee, Kyu Taek Lee, Poong-Lyul Rhee, Jae J. Kim, Eliseo Guallar, Juhee Cho, Hyuk Lee. Use of proton pump inhibitors and the risk of cholangitis: a nationwide cohort study. Aliment Pharmacol Ther 2019;50:760
    https://doi.org/10.1111/apt.15466
  10. Taned Chitapanarux, Nirush Lertprasertsuke, Acharaporn Kongnak. Teprenone for the prevention of low-dose aspirin-induced gastric mucosal injury in Helicobacter pylori-negative patients. Scandinavian Journal of Gastroenterology 2019:1
    https://doi.org/10.1080/00365521.2019.1672781
  11. Michal Novotny, Blanka Klimova, Martin Valis. PPI Long Term Use: Risk of Neurological Adverse Events?. Front. Neurol. 2019;9
    https://doi.org/10.3389/fneur.2018.01142
  12. Richard H. Hunt, Carmelo Scarpignato. Potent Acid Suppression with PPIs and P-CABs: What’s New?. Curr Treat Options Gastro 2018;16:570
    https://doi.org/10.1007/s11938-018-0206-y
  13. Fazila Rizvi, Majid Khan, Almas Jabeen, Hina Siddiqui, M. Iqbal Choudhary. Studies on Isoniazid Derivatives through a Medicinal Chemistry Approach for the Identification of New Inhibitors of Urease and Inflammatory Markers. Sci Rep 2019;9
    https://doi.org/10.1038/s41598-019-43082-0